Gadolinium based contrast agents have been associated with an increased risk of a skin disorder known as nephrogenic systemic fibrosis, or NSF. The FDA has recently asked the manufacturer of Gadolinium to update its warning to include the risk of nephrogenic systemic fibrosis. If you or anyone you know has experienced nephrogenic systemic fibrosis as a result of Gadolinium, contact a lawyer at Carey & Danis immediately.

The experienced lawyers at Carey & Danis are committed to helping the victims of nephrogenic systemic fibrosis as a result of gadolinium based contrast agents obtain the compensation they deserve for their injuries. Carey & Danis will aggressively prosecute its clients cases to a successful resolution.

The FDA has approved five gadolinium based contrast agents. The names of these agents are Omniscan, OptiMARK, ProHance, MultiHance, and Magnevist. If you have been adversely affected by one of these gadolinium based contrast agents, contact one of the lawyers at Carey & Danis immediately to discuss your case.

These gadolinium based contrast agents cause nephrogenic systemic fibrosis. Nephrogenic systemic fibrosis is a hardening of the skin and connective tissue. This hardening can cause restricted movement of the joints and can eventually lead to organ damage and even death. NSF is most commonly found in people with severe kidney damage.

Carey & Danis is committed to helping those harmed by corporations and other negligent parties. We have the team and resources to effectively pursue cases such as these. If you have been affected by Gadolinium based contrast agents, please contact an attorney at Carey & Danis to discuss your legal rights.